Ophthalmology’s Role in the Opioid Crisis
Retrospective cohort study investigates how ophthalmologists can provide potentially life-saving care to substance use disorder patients
-
By
-
Alun Evans
-
March 19, 2026
-
Clinical Scorecard: Ophthalmology’s Role in the Opioid Crisis
At a Glance
| Category | Detail |
|---|
| Condition | Injection drug use–associated endogenous endophthalmitis (IDU-EE) |
| Key Mechanisms | Opioid use, particularly fentanyl, linked to severe ocular disease and worse visual outcomes. |
| Target Population | Patients with substance use disorders, particularly those who inject drugs. |
| Care Setting | Inpatient hospital settings, particularly emergency departments. |
Key Highlights
- IDU-EE presents a critical opportunity for early intervention in substance use disorders.
- Fentanyl use is associated with worse visual outcomes compared to other drugs.
- Aggressive ophthalmic treatment should be combined with addiction consultation.
- Routine addiction consult involvement is recommended for managing IDU-EE.
- Hospitalization is a key moment to connect patients with evidence-based addiction treatments.
Guideline-Based Recommendations
Diagnosis
- Look for acute vision loss, floaters, eye pain, or photophobia in patients who inject drugs.
- Utilize slit lamp and indirect ophthalmoscopy for diagnosis.
Management
- Treat IDU-EE as a dual emergency with aggressive ophthalmic treatment and addiction consultation.
Monitoring & Follow-up
- Ensure follow-up care and connection to harm-reduction services.
Risks
- Failure to involve addiction consults may lead to missed treatment opportunities for opioid use disorder.
Patient & Prescribing Data
Patients hospitalized with IDU-EE and substance use disorders.
No opioid use disorder medication was administered without addiction consult involvement.
Clinical Best Practices
- Normalize addiction consult involvement in the management of IDU-EE.
- Utilize hospitalization as a touchpoint for initiating addiction treatments.
References
